1
|
William N, Bicahlo B, Hansen A, de Korte D, Acker JP. The timing of gamma irradiation and its effect on c
ell‐free
and m
icrovesicle‐bound
hemoglobin. The
BEST
collaborative study. Transfusion 2022; 62:751-757. [DOI: 10.1111/trf.16809] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2021] [Revised: 01/09/2022] [Accepted: 01/09/2022] [Indexed: 11/28/2022]
Affiliation(s)
- Nishaka William
- Department of Laboratory Medicine and Pathology University of Alberta Edmonton Alberta Canada
| | - Beatriz Bicahlo
- Innovation and Portfolio Management Canadian Blood Services Edmonton Alberta Canada
| | - Adele Hansen
- Innovation and Portfolio Management Canadian Blood Services Edmonton Alberta Canada
| | - Dirk de Korte
- Department Product and Process Development Sanquin Blood Bank Amsterdam Netherlands
- Department Blood Cell Research Sanquin Research Amsterdam Netherlands
| | - Jason P. Acker
- Department of Laboratory Medicine and Pathology University of Alberta Edmonton Alberta Canada
| | | |
Collapse
|
2
|
Orsi KCSC, Kita VY, de Souza AHP, Tsunemi MH, Avelar AFM. Neonatal Transfusion Practice: Hemolysis Markers After In Vitro Infusion of Packed Red Blood Cells by the Gravitational Method or Syringe Pump in a Peripheral Catheter. J Perinat Neonatal Nurs 2021; 35:E40-E49. [PMID: 34726655 DOI: 10.1097/jpn.0000000000000571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
The objective of this study was to verify the influence of the gravitational infusion method or syringe infusion pump on changes in hemolysis markers of irradiated and nonirradiated packed red blood cells (PRBCs) in vitro administered in a neonate peripheral intravenous catheter. An experimental study was conducted in a laboratory under controlled environmental conditions. Irradiated and nonirradiated PRBCs were administered in triplicate by the gravitational method and 10-mL/hour syringe infusion pump, in peripheral intravenous catheter, Vialon, 24-G caliber. Aliquots were collected directly from the PRBC bag, after manual filling of the infusion system and after infusion by the catheters. The following hemolytic markers were analyzed: degree of hemolysis (%), hematocrit (Ht, %), free hemoglobin (fHb, g/dL), potassium (K, mmol/L), and lactate dehydrogenase (LDH, U/L). Mann-Whitney and Student's t tests were used, P ≤ .05. The gravitational method significantly influenced increasing fHb (P = .007), Ht (P = .002), K (P = .002), and LDH (P = .003) values after PRBC irradiated infusion. The infusion of irradiated and non-irradiated PRBCs interferes with changes in hemolytic markers with the gravitational method. Syringe infusion pump proved to be a beneficial and safe alternative to irradiated and nonirradiated PRBC transfusion in newborns.
Collapse
Affiliation(s)
- Kelly Cristina Sbampato Calado Orsi
- Nursing School, Federal University of São Paulo, São Paulo, Brazil (Drs Orsi and Avelar and Mss Kita and de Souza); and Department of Biostatistics, Paulista State University Julio de Mesquita Filho, Botucatu, São Paulo, Brazil (Dr Tsunemi)
| | | | | | | | | |
Collapse
|
3
|
The Effects of Medical Diagnostic Low Dose X-rays after in vitro Exposure of Human Red Blood Cells: Hemolysis and Osmotic Fragility. TOXICOLOGY AND ENVIRONMENTAL HEALTH SCIENCES 2019. [DOI: 10.1007/s13530-019-0409-1] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
4
|
Dimberg LY, Doane SK, Yonemura S, Reddy HL, Hovenga N, Gosney EJ, Tran M, Wilkinson S, Goodrich RP, Marschner S. Red Blood Cells Derived from Whole Blood Treated with Riboflavin and UV Light Maintain Adequate Cell Quality through 21 Days of Storage. Transfus Med Hemother 2019; 46:240-247. [PMID: 31700506 PMCID: PMC6739696 DOI: 10.1159/000495257] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2018] [Accepted: 11/09/2018] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND The Mirasol system for whole blood (WB) is a non-toxic, non-mutagenic pathogen reduction technology (PRT) that treats WB units with riboflavin (vitamin B2) and ultraviolet (UV) light to alter nucleic acids, thereby reducing pathogen infectivity and inactivating white blood cells. This study evaluates the quality of red blood cells (RBCs) derived from WB treated with the Mirasol system. STUDY DESIGN AND METHODS Paired units of WB were collected from 61 healthy donors. One unit per donor was treated with riboflavin and UV light and the other was used as an untreated control. RBCs were processed from the WB units and stored in AS-3 at 1-6°C for 21 days and sampled for in vitro analyses of RBC quality parameters. RESULTS Several statistically significant differences were observed between test and control units, but values were overall within normal clinical ranges. After leukoreduction, the residual leukocyte count and RBC recovery met FDA requirements. The RBC units derived from treated WB maintained haemolysis below 1% through 21 days of storage. CONCLUSION RBCs derived from WB treated with the Mirasol system meet accepted FDA guidelines for RBC quality through 21 days of storage at 1-6°C.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - Raymond P. Goodrich
- Infectious Disease Research Center, Colorado State University, Fort Collins, Colorado, USA
| | | |
Collapse
|
5
|
Levels of Hemolysis Markers in Erythrocyte Concentrates Administered Using a Syringe Infusion Pump. JOURNAL OF INFUSION NURSING 2018; 41:180-188. [PMID: 29659466 DOI: 10.1097/nan.0000000000000280] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Syringe infusion pumps (SIPs) led to major advances in infusion therapy and were gradually applied to the transfusion of packed red blood cells (RBCs), raising questions about possible cell damage. The objectives of this study were to determine levels of hematocrit (%), total hemoglobin (g/dL), free hemoglobin (g/dL), lactate dehydrogenase (units/L), potassium (mmol/L), the degree of hemolysis (%) of RBCs infused by an SIP, and to investigate the influence of the infusion rate. The experimental study comprised 14 RBCs, 3 SIPs, and infusion rates of 5, 10, and 20 mL/h. The results showed total hemoglobin reduction (P = .003), and increased free hemoglobin and hemolysis (P <.001) were identified. The conclusion reached was that RBCs presented changes in free hemoglobin and degree of hemolysis.
Collapse
|
6
|
de Korte D, Thibault L, Handke W, Harm SK, Morrison A, Fitzpatrick A, Marks DC, Yi QL, Acker JP. Timing of gamma irradiation and blood donor sex influences in vitro characteristics of red blood cells. Transfusion 2018; 58:917-926. [DOI: 10.1111/trf.14481] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2017] [Revised: 11/23/2017] [Accepted: 11/27/2017] [Indexed: 01/08/2023]
Affiliation(s)
- Dirk de Korte
- Research and Development; Sanquin Blood Bank; Amsterdam the Netherlands
| | - Louis Thibault
- Research and Development; Héma-Québec; Québec City Québec Canada
| | - Wiebke Handke
- German Red Cross Blood Service NSTOB; Springe Germany
| | - Sarah K. Harm
- University of Pittsburgh Medical Center and the Institute for Transfusion Medicine; Pittsburgh Pennsylvania
| | - Alex Morrison
- Scottish National Blood Transfusion Service; Edinburgh Scotland
| | | | - Denese C. Marks
- Research and Development; Australian Red Cross Blood Service; Sydney New South Wales Australia
| | - Qi-Long Yi
- Centre for Innovation; Canadian Blood Service; Edmonton Alberta Canada
| | - Jason P. Acker
- Centre for Innovation; Canadian Blood Service; Edmonton Alberta Canada
| | | |
Collapse
|
7
|
Favrais G, Wibaut B, Pladys P, Saliba E. Transfusion de culot globulaire chez le nouveau-né grand prématuré : ce qui a changé dans les recommandations françaises depuis 2002. Arch Pediatr 2017; 24:894-901. [DOI: 10.1016/j.arcped.2017.06.014] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2016] [Revised: 05/01/2017] [Accepted: 06/22/2017] [Indexed: 12/17/2022]
|
8
|
Acker JP, Marks DC, Sheffield WP. Quality Assessment of Established and Emerging Blood Components for Transfusion. JOURNAL OF BLOOD TRANSFUSION 2016; 2016:4860284. [PMID: 28070448 PMCID: PMC5192317 DOI: 10.1155/2016/4860284] [Citation(s) in RCA: 53] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/31/2016] [Accepted: 11/02/2016] [Indexed: 12/16/2022]
Abstract
Blood is donated either as whole blood, with subsequent component processing, or through the use of apheresis devices that extract one or more components and return the rest of the donation to the donor. Blood component therapy supplanted whole blood transfusion in industrialized countries in the middle of the twentieth century and remains the standard of care for the majority of patients receiving a transfusion. Traditionally, blood has been processed into three main blood products: red blood cell concentrates; platelet concentrates; and transfusable plasma. Ensuring that these products are of high quality and that they deliver their intended benefits to patients throughout their shelf-life is a complex task. Further complexity has been added with the development of products stored under nonstandard conditions or subjected to additional manufacturing steps (e.g., cryopreserved platelets, irradiated red cells, and lyophilized plasma). Here we review established and emerging methodologies for assessing blood product quality and address controversies and uncertainties in this thriving and active field of investigation.
Collapse
Affiliation(s)
- Jason P. Acker
- Centre for Innovation, Canadian Blood Services, Edmonton, AB, Canada
- Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada
| | - Denese C. Marks
- Research and Development, Australian Red Cross Blood Service, Sydney, NSW, Australia
| | - William P. Sheffield
- Centre for Innovation, Canadian Blood Services, Hamilton, ON, Canada
- Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada
| |
Collapse
|
9
|
Fujita H, Okuda M, Ohara A, Kajiwara M, Koyama N, Takano H, Hosono S, Matsuzaki K, Yazawa Y, Maeda H, Miyata S. STANDARDIZED METHODS FOR IN-HOUSE SEPARATION OF A BLOOD PRODUCT FOR MULTIPLE USE. ACTA ACUST UNITED AC 2016. [DOI: 10.3925/jjtc.62.673] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- Hiroshi Fujita
- Task Force on Standardized Methods for In-house Separation of a Blood Product for Multiple Use, Committee on Appropriate Blood Product Modifications, The Japan Society of Transfusion Medicine and Cell Therapy
- Department of Transfusion Medicine, Tokyo Metropolitan Bokutoh Hospital
| | - Makoto Okuda
- Task Force on Standardized Methods for In-house Separation of a Blood Product for Multiple Use, Committee on Appropriate Blood Product Modifications, The Japan Society of Transfusion Medicine and Cell Therapy
- Division of Blood Transfusion, Toho University Omori Medical Center
| | - Akira Ohara
- Task Force on Standardized Methods for In-house Separation of a Blood Product for Multiple Use, Committee on Appropriate Blood Product Modifications, The Japan Society of Transfusion Medicine and Cell Therapy
- Department of Pediatrics, Toho University School of Medicine
| | - Michiko Kajiwara
- Task Force on Standardized Methods for In-house Separation of a Blood Product for Multiple Use, Committee on Appropriate Blood Product Modifications, The Japan Society of Transfusion Medicine and Cell Therapy
- Department of Transfusion Medicine, Medical Hospital, Tokyo Medical and Dental University
| | - Norihisa Koyama
- Task Force on Standardized Methods for In-house Separation of a Blood Product for Multiple Use, Committee on Appropriate Blood Product Modifications, The Japan Society of Transfusion Medicine and Cell Therapy
- Department of Pediatrics, Toyohashi Municipal Hospital
| | - Hisayo Takano
- Task Force on Standardized Methods for In-house Separation of a Blood Product for Multiple Use, Committee on Appropriate Blood Product Modifications, The Japan Society of Transfusion Medicine and Cell Therapy
- Division of Blood Transfusion, St Mary's Hospital
| | - Shigeharu Hosono
- Task Force on Standardized Methods for In-house Separation of a Blood Product for Multiple Use, Committee on Appropriate Blood Product Modifications, The Japan Society of Transfusion Medicine and Cell Therapy
- Department of Pediatrics and Child Health, Nihon University School of Medicine
| | - Koji Matsuzaki
- Task Force on Standardized Methods for In-house Separation of a Blood Product for Multiple Use, Committee on Appropriate Blood Product Modifications, The Japan Society of Transfusion Medicine and Cell Therapy
- Japanese Red Cross Fukuoka Blood Center
| | - Yurika Yazawa
- Task Force on Standardized Methods for In-house Separation of a Blood Product for Multiple Use, Committee on Appropriate Blood Product Modifications, The Japan Society of Transfusion Medicine and Cell Therapy
- Division of Blood Transfusion, Tokyo Metropolitan Children's Medical Center
| | - Hiroo Maeda
- Task Force on Standardized Methods for In-house Separation of a Blood Product for Multiple Use, Committee on Appropriate Blood Product Modifications, The Japan Society of Transfusion Medicine and Cell Therapy
- Department of Transfusion Medicine and Cell Therapy, Saitama Medical Center, Saitama Medical University
| | - Shigeki Miyata
- Task Force on Standardized Methods for In-house Separation of a Blood Product for Multiple Use, Committee on Appropriate Blood Product Modifications, The Japan Society of Transfusion Medicine and Cell Therapy
- Division of Transfusion Medicine, National Cerebral and Cardiovascular Center
| |
Collapse
|
10
|
Winter KM, Johnson L, Webb RG, Marks DC. Gamma-irradiation of deglycerolized red cells does not significantly affect in vitro quality. Vox Sang 2015; 109:231-8. [PMID: 25953334 DOI: 10.1111/vox.12282] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2014] [Revised: 02/11/2015] [Accepted: 03/11/2015] [Indexed: 11/29/2022]
Abstract
BACKGROUND AND OBJECTIVES Red cells frozen with glycerol may require gamma-irradiation after thawing and deglycerolization for transfusion to at-risk patients. Both freezing and irradiation are known to cause red cell damage. However, the effect of irradiation on the quality of deglycerolized red cells and the optimal shelf life of such a component is currently unknown. MATERIALS AND METHODS Red cells (<7 days) were pooled, split and glycerolized using an ACP-215 automated cell washer (n = 12 pairs) and frozen at -80°C. Red cells were thawed, deglycerolized and resuspended in SAG-M. One of each pair was gamma-irradiated, while the other served as a control. Products were stored at 2-6°C and sampled for in vitro testing immediately after irradiation, and at 24 and 48 h postirradiation. RESULTS Irradiation of deglycerolized red cells led to a >1·5-fold increase in extracellular potassium, compared to control units at 24 and 48 h postirradiation. Other parameters, including haemolysis, were not significantly affected by irradiation postdeglycerolization. CONCLUSION Deglycerolized, irradiated red cells had increased supernatant potassium, but remained of acceptable quality for 24 h postirradiation.
Collapse
Affiliation(s)
- K M Winter
- Research and Development, Australian Red Cross Blood Service, Sydney, NSW, Australia
| | - L Johnson
- Research and Development, Australian Red Cross Blood Service, Sydney, NSW, Australia
| | - R G Webb
- Research and Development, Australian Red Cross Blood Service, Sydney, NSW, Australia
| | - D C Marks
- Research and Development, Australian Red Cross Blood Service, Sydney, NSW, Australia
| |
Collapse
|